{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:16:33Z","timestamp":1791926193812,"version":"4.3.4"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100017501","name":"Science-Health Joint Medical Scientific Research Project of Chongqing","doi-asserted-by":"publisher","award":["2021MSXM339"],"award-info":[{"award-number":["2021MSXM339"]}],"id":[{"id":"10.13039\/100017501","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82001434"],"award-info":[{"award-number":["82001434"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005230","name":"Chongqing Natural Science Foundation","doi-asserted-by":"publisher","award":["cstc2020jcyj-msxmX0149"],"award-info":[{"award-number":["cstc2020jcyj-msxmX0149"]}],"id":[{"id":"10.13039\/501100005230","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2022M710562"],"award-info":[{"award-number":["2022M710562"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022756","name":"Centre for Human Drug Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022756","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013373","name":"NIHR Oxford Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013373","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jad.2025.120087","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T12:45:08Z","timestamp":1755693908000},"page":"120087","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Efficacy and tolerability of pramipexole versus antidepressants for Parkinson's disease with depression: a meta-analysis of randomized controlled trials"],"prefix":"10.1016","volume":"392","author":[{"given":"Xue","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fenghua","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Browning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyin","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jad.2025.120087_bb0005","article-title":"Parkinson disease-associated cognitive impairment","volume":"7","author":"Aarsland","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.jad.2025.120087_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101840","article-title":"Neurobiology of depression in Parkinson\u2019s disease: insights into epidemiology, molecular mechanisms and treatment strategies","volume":"85","author":"Ahmad","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.jad.2025.120087_bb0015","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00415-008-5004-3","article-title":"Epidemiology of Parkinson\u2019s disease","volume":"255","author":"Alves","year":"2008","journal-title":"J. Neurol."},{"issue":"6","key":"10.1016\/j.jad.2025.120087_bb0020","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1001\/jama.2019.22360","article-title":"Diagnosis and treatment of Parkinson disease: a review","volume":"323","author":"Armstrong","year":"2020","journal-title":"Jama"},{"issue":"10","key":"10.1016\/j.jad.2025.120087_bb0025","first-page":"966","article-title":"Neuroanatomical and prognostic associations of depression in Parkinson\u2019s disease","volume":"95","author":"Badenoch","year":"2024","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"5","key":"10.1016\/j.jad.2025.120087_bb0030","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00415-006-0067-5","article-title":"Pramipexole versus sertraline in the treatment of depression in Parkinson\u2019s disease: a national multicenter parallel-group randomized study","volume":"253","author":"Barone","year":"2006","journal-title":"J. Neurol."},{"issue":"6","key":"10.1016\/j.jad.2025.120087_bb0035","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1474-4422(10)70106-X","article-title":"Pramipexole for the treatment of depressive symptoms in patients with Parkinson\u2019s disease: a randomised, double-blind, placebo-controlled trial","volume":"9","author":"Barone","year":"2010","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.jad.2025.120087_bb0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.105136","article-title":"Molecular mechanisms of psychiatric diseases","volume":"146","author":"Blokhin","year":"2020","journal-title":"Neurobiol. Dis."},{"issue":"8","key":"10.1016\/j.jad.2025.120087_bb0045","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.parkreldis.2015.04.018","article-title":"Antidepressive treatments for Parkinson\u2019s disease: a systematic review and meta-analysis","volume":"21","author":"Bomasang-Layno","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"issue":"4","key":"10.1016\/j.jad.2025.120087_bb0050","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/WNF.0000000000000507","article-title":"Comparative analysis of the effects of escitalopram, Pramipexole, and transcranial magnetic stimulation on depression in patients with Parkinson disease: an open-label randomized controlled trial","volume":"45","author":"Chen","year":"2022","journal-title":"Clin. Neuropharmacol."},{"issue":"1","key":"10.1016\/j.jad.2025.120087_bb0055","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1186\/s12877-017-0666-2","article-title":"Prevalence and risk factors for depression and anxiety in Chinese patients with Parkinson disease","volume":"17","author":"Cui","year":"2017","journal-title":"BMC Geriatr."},{"issue":"10","key":"10.1016\/j.jad.2025.120087_bb0060","article-title":"Updated guidance for trusted systematic reviews: a new edition of the Cochrane handbook for systematic reviews of interventions","volume":"10","author":"Cumpston","year":"2019","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"10.1016\/j.jad.2025.120087_bb0065","first-page":"188","article-title":"Clinical efficacy of proxol in the treatment of Parkinson's disease with depression","volume":"18","author":"Dai","year":"2010","journal-title":"Chin. J. Clin. Neurosci."},{"issue":"6","key":"10.1016\/j.jad.2025.120087_bb0070","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1002\/mds.21966","article-title":"Comparison of desipramine and citalopram treatments for depression in Parkinson\u2019s disease: a double-blind, randomized, placebo-controlled study","volume":"23","author":"Devos","year":"2008","journal-title":"Mov. Disord."},{"issue":"13","key":"10.1016\/j.jad.2025.120087_bb0075","first-page":"14","article-title":"Clinical observation of the antidepression effect of Pramipexole in Parkinson'S disease with depression","volume":"15","author":"Fan","year":"2012","journal-title":"Chin. J. Pract. Nerv. Dis."},{"issue":"7","key":"10.1016\/j.jad.2025.120087_bb0080","first-page":"787","article-title":"A comparative study of pramexole in the treatment of depressive disorder associated with Parkinson's disease","volume":"13","author":"Fang","year":"2011","journal-title":"Zhejiang Clin. Med. J."},{"key":"10.1016\/j.jad.2025.120087_bb0085","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108392","article-title":"The complex molecular pharmacology of the dopamine D(2) receptor: implications for pramipexole, ropinirole, and rotigotine","volume":"245","author":"Ferraiolo","year":"2023","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.jad.2025.120087_bb0090","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1136\/jnnp-2016-314832","article-title":"Risk factors for early psychosis in PD: insights from the Parkinson\u2019s progression markers initiative","volume":"88","author":"Ffytche","year":"2017","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2025.120087_bb0095","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.biopsych.2023.05.023","article-title":"Pramipexole enhances reward learning by preserving value estimates","volume":"95","author":"Halahakoon","year":"2024","journal-title":"Biol. Psychiatry"},{"issue":"3","key":"10.1016\/j.jad.2025.120087_bb0100","first-page":"1757","article-title":"Efficacy and safety of pramipexole in Parkinson's disease with anxiety or depression: a meta-analysis of randomized clinical trials","volume":"14","author":"Ji","year":"2022","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.jad.2025.120087_bb0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajp.2021.102691","article-title":"The role of pramipexole in the treatment of patients with depression and Parkinson\u2019s disease: a meta-analysis of randomized controlled trials","volume":"61","author":"Jiang","year":"2021","journal-title":"Asian J. Psychiatr."},{"issue":"10","key":"10.1016\/j.jad.2025.120087_bb0110","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/s41419-020-03085-6","article-title":"Amitriptyline interferes with autophagy-mediated clearance of protein aggregates via inhibiting autophagosome maturation in neuronal cells","volume":"11","author":"Kwon","year":"2020","journal-title":"Cell Death Dis."},{"issue":"11","key":"10.1016\/j.jad.2025.120087_bb0115","article-title":"Selective serotonin reuptake inhibitors (SSRIs) for stroke recovery","volume":"11","author":"Legg","year":"2021","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.jad.2025.120087_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108237","article-title":"SNRIs achieve faster antidepressant effects than SSRIs by elevating the concentrations of dopamine in the forebrain","volume":"177","author":"Li","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jad.2025.120087_bb0125","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"Bmj"},{"issue":"1","key":"10.1016\/j.jad.2025.120087_bb0130","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s12974-022-02597-6","article-title":"\u03b2-Arrestin2-biased Drd2 agonist UNC9995 alleviates astrocyte inflammatory injury via interaction between \u03b2-arrestin2 and STAT3 in mouse model of depression","volume":"19","author":"Liu","year":"2022","journal-title":"J. Neuroinflammation"},{"issue":"8","key":"10.1016\/j.jad.2025.120087_bb0135","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s00415-011-6392-3","article-title":"Gender-related differences in the burden of non-motor symptoms in Parkinson\u2019s disease","volume":"259","author":"Martinez-Martin","year":"2012","journal-title":"J. Neurol."},{"issue":"11","key":"10.1016\/j.jad.2025.120087_bb0140","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/mds.10538","article-title":"Randomized, double-blind, 3-month parallel study of the effects of pramipexole, pergolide, and placebo on parkinsonian tremor","volume":"18","author":"Navan","year":"2003","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jad.2025.120087_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2021.106780","article-title":"Fluoxetine as adjunctive therapy in pediatric patients with refractory epilepsy: a retrospective analysis","volume":"177","author":"Neveu","year":"2021","journal-title":"Epilepsy Res."},{"issue":"S2","key":"10.1016\/j.jad.2025.120087_bb0150","first-page":"5069","article-title":"The randomized controlled trial of pramipexole treatment of Parkinson's disease and depression","volume":"11","author":"Qian","year":"2011","journal-title":"Prog. Mod. Biomed."},{"issue":"3","key":"10.1016\/j.jad.2025.120087_bb0155","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3109\/10401239409149001","article-title":"Diagnostic and statistical manual of mental disorders, 3rd ed. (DSM-III), adaptive functioning in young Swedish suicides","volume":"6","author":"Runeson","year":"1994","journal-title":"Ann. Clin. Psychiatry"},{"issue":"2","key":"10.1016\/j.jad.2025.120087_bb0160","first-page":"40","article-title":"Updating the international classification of diseases and related health problems, tenth revision (ICD-10)","volume":"39","author":"Rust","year":"2010","journal-title":"Health Inf. Manag."},{"key":"10.1016\/j.jad.2025.120087_bb0165","first-page":"1","article-title":"A randomized controlled trial of pramipexole versus fluoxetine in the treatment of depression in Parkinson's disease","volume":"01","author":"Su","year":"2010","journal-title":"Chin. J. Geriatr."},{"issue":"5","key":"10.1016\/j.jad.2025.120087_bb0170","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/S1474-4422(21)00030-2","article-title":"Challenges in the diagnosis of Parkinson\u2019s disease","volume":"20","author":"Tolosa","year":"2021","journal-title":"Lancet Neurol."},{"issue":"5","key":"10.1016\/j.jad.2025.120087_bb0175","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1136\/rapm-2019-101207","article-title":"Serotonin-norepinephrine reuptake inhibitors for the prevention of migraine and vestibular migraine: a systematic review and meta-analysis","volume":"45","author":"Wang","year":"2020","journal-title":"Reg. Anesth. Pain Med."},{"key":"10.1016\/j.jad.2025.120087_bb0180","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175070","article-title":"Comparative efficacy and acceptability of drug treatments for Parkinson\u2019s disease with depression: a systematic review with network meta-analysis","volume":"927","author":"Wang","year":"2022","journal-title":"Eur. J. Pharmacol."},{"issue":"02","key":"10.1016\/j.jad.2025.120087_bb0185","first-page":"118","article-title":"Randomized controlled study of pramipexole, fluoxetine and duloxetine in the treatment of depressive state in Parkinson's disease","volume":"37","author":"Wang","year":"2020","journal-title":"J. Clin. Intern. Med."},{"issue":"20","key":"10.1016\/j.jad.2025.120087_bb0190","first-page":"113","article-title":"Efficacy of pramexole and flupentixol melitracen in the treatment of Parkinson's disease combined with depression","volume":"15","author":"Wu","year":"2015","journal-title":"World Latest Medicine Information"},{"issue":"32","key":"10.1016\/j.jad.2025.120087_bb0195","first-page":"64","article-title":"Clinical effect of Pramipexole and escitalopram in the treatment of patients with Parkinson\u2019s disease and depression","volume":"17","author":"Yang","year":"2020","journal-title":"China medical herald"},{"issue":"07","key":"10.1016\/j.jad.2025.120087_bb0200","first-page":"908","article-title":"Clinical efficacy and safety of pramipexole in the treatment of depressive disorder associated with Parkinson's disease","volume":"31","author":"Zhang","year":"2010","journal-title":"Guangdong Med. J."},{"issue":"1","key":"10.1016\/j.jad.2025.120087_bb0205","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s12888-021-03253-8","article-title":"Venlafaxine vs. fluoxetine in postmenopausal women with major depressive disorder: an 8-week, randomized, single-blind, active-controlled study","volume":"21","author":"Zhou","year":"2021","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.jad.2025.120087_bb0210","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4103\/jrms.jrms_790_21","article-title":"Comparison of pramipexole and citalopram in the treatment of depression in Parkinson\u2019s disease: a randomized parallel-group trial","volume":"27","author":"Ziaei","year":"2022","journal-title":"J. Res. Med. Sci."}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725015290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165032725015290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,31]],"date-time":"2026-05-31T05:18:48Z","timestamp":1780204728000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165032725015290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":42,"alternative-id":["S0165032725015290"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2025.120087","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and tolerability of pramipexole versus antidepressants for Parkinson's disease with depression: a meta-analysis of randomized controlled trials","name":"articletitle","label":"Article Title"},{"value":"Journal of Affective Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jad.2025.120087","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"120087"}}